Member Info for Darwen68

Needed that amount of money in a hurry !!.

Just people fed up waiting for anything positive.
Price still a good deal before last placing.
There's a reason for that.

Are we all ready for this to be kicked into the long grass again?

If Dr Cave were having a drink in the pub with braveheart's Dr Smythe and hemogenyx Dr Sandler I would be surprised if they could find the toilet let alone a scientific breakthrough.

Any placing will not be based on a forthcoming deal or any announcement of future revenue.
It would be to "keep the lights on" like the last one.

Let's hope for another 12.

Says who?

Wonder if the sepsis trial has failed to produce anything of value.
That would be added to the failures of alzheimers/dementia and covid trials for our illustrious scientist.
Maybe 4th time lucky !!

Dear Dawn,
Certainly not obvious it was a copy and paste unless you read the article from the ADVFN site.Why copy and paste information you know to be false without a clarification.
If you believe that article reads as a 50/50 chance of DKE survival my patronising needle goes of the dial.
We can agree Chaiwalla offers nothing to the debate.

Yours
Darwen (patronising)

Who is going to be the first person to tell Dawn that DKE is not an AIM listing.
Nobody on this chat board really understands the rules and regulations of timelines and company rules (me included). - there seems always an allowable extension for one reason or another.
As speculators we will find out one day or another if there is a future for DKE.

Think "puddle of blue" is more apt.

Looks like the highlight of Filtech was the in- flight meal.

Interesting that we were due results in Feb.
And there's nobody commenting on what,when and how much.

We are all resigned to delay and mistruths from another aim gravy train.

More patience needed !!!!!.
Classic.

........and the can gets kicked further into the long grass.

Wala
If you've kissed goodbye to this share why do you still comment.
You should kiss goodbye to the rest of us and disappear.

No doubt big pharma has hemo on their radar along with a host of other small tech pharma with similar science in development.

The research could certainly lead to a market worth multi millions or even billion with one caveat - an awful lot more funding,trials and time.
Share price tend to be forward thinking so with all the frenzied excitement,guessing this date or that date,this value or that value and an unhealthy addiction to a mans' twitter feed, hemo sits at 2.something p still below a recent placing.

It would seem nobody with deep pockets is willing to take the risk - plenty could afford it easily.

Vlad has dangled carrots for years,relinquishing little and made poor financial decisions.

Share4life.
You say "spot on JHFH".

How can you be "spot on" with wild speculation on total hypothetical scenarios.

Uneducated valuations lead to wild hysteria of share price movements and company valuations.

Put a title of "takeover" and the sadly deluded get hypnotised into a belief of unrealistic expectations.
Vlad has a track record of poor business acumen and his twitter feed is still somehow seen as relevant even if he's watching a ball game or mentioning song titles from yesteryear.

With Vlad track record you missed.

Delays (100%)

Condom.
I take it you want some attention.

We might need a bigger coop.!!